"Can we cure, prevent or manage all disease by the end of this century?" asked by Facebook founder, Mark Zuckerberg.
In September 2016, Zuckerberg, along with Dr. Priscilla Chan, who heads the Chan-Zuckerberg Initiative (a limited liability company that they use to make donations and investments to advance their philanthropic causes), have rolled out their plans in investing their $3Billion in the next 10 years to fund medical research and scientific innovation. It aims to tackle all diseases including some of the biggest killers in the world today like heart disease, cancer, infectious diseases, and neurological diseases.
The philanthropic initiative was highly commended by Microsoft founder, Bill Gates, who, like Zuckerberg, has started the Bill & Melinda Gates Foundation, which aims to bridge the enormous health gap between rich and poor countries (among their foundation's goals are the eradication of malaria and polio, and controlling the spread of tuberculosis and HIV).
The Chan-Zuckerberg Initiative in its early stages is already showing promising and exciting projects - starting with BioHub, a program which aims to funding scientists, technologists and engineers in bringing fresh ideas to solving medical problems and building technologies to aid science.
Here's a look at three of their latest research and how it aims to shape the fields of science, medicine, healthcare and technology: